Biomaterials-Driven Sterile Inflammation

Tissue Eng Part B Rev. 2022 Feb;28(1):22-34. doi: 10.1089/ten.TEB.2020.0253. Epub 2021 Feb 23.

Abstract

Performance of the biomaterials used for regenerative medicine largely depends on biocompatibility; however, the biological mechanisms underlying biocompatibility of a biomaterial within the host system is poorly understood. In addition to the classical immune response against non-self-entities, the sterile inflammatory response could limit the compatibility of biological scaffolds. Whereas the immediate to short-term host response to a biomaterial implant have been characterized, the long-term progression of host-biomaterial relationship has not been described. This article explores the novel concept of biomaterials-driven sterile inflammation (BSI) in long-term biodegradable implants and throws light for possible explanation for the onset of BSI and the associated damage-associated molecular patterns. The understanding of BSI would advance the current strategies to improve biomaterial-host tissue integration and open novel translational avenues in biomaterials-based tissue regeneration. Impact statement Understanding the novel concept of biomaterials-driven sterile inflammation and associated damage-associated molecular patterns in long-term biodegradable implants would determine their success and improves the tissue engineering and regenerative strategies.

Keywords: DAMPs; biocompatibility; biomaterials; implant immunology; sterile inflammation.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Biocompatible Materials* / adverse effects
  • Humans
  • Inflammation
  • Prostheses and Implants
  • Regenerative Medicine
  • Tissue Engineering*

Substances

  • Biocompatible Materials